国产a级特黄的片子,精品香蕉一区二区三区,亚洲精品99久久久久中文字幕,无码精品A∨在线观看无广告

Stock(600222)Hot line:010-61006450

News

Understand the latest news of Leadingpharm

Congratulations on the Second Anniversary of the Establishment of Hangzhou Conlead, A New Star in Pediatric Drug Research and Development Shines Brightly

Release time:2024-05-28

Hangzhou Conlead, founded by Leadingpharm and Huluwa, has been focusing on the research and development of high-end pediatric formulations since its inception in 2022, shouldering the mission of solving medication problems for children and the elderly. Over the past two years, this young pharmaceutical research and development enterprise has gradually emerged with continuous technological innovation and strong research and development capabilities, committed to becoming a leading brand in the field of pediatric medicine in China.
 

 
Recently, the Hangzhou Municipal Bureau of Science and Technology announced the list of Hangzhou Enterprise High-tech Research and Development Centers of 2024, with Hangzhou Conlead on it. This honor marks the significant achievements of Conlead in the field of research and development of pediatric medicine and improved new drug. As an independent research and development institution within the enterprise, the high-tech research and development center is not only an important platform for technological innovation and achievement transformation, but also a key force in enhancing the core competitiveness of the enterprise.

 

Within two years, Conlead has established multiple formulation platforms, including oral films, complex particles, and special oral solutions, achieving comprehensive coverage in the fields of chemical medicine, traditional Chinese medicine and biopharmaceuticals. Its professional abilities in pharmaceutical research, in vitro and in vivo evaluation, and registration application have been widely recognized in the industry. At present, with the support and collaboration of experts and R&D teams of Leadingpharm, Conlead has formed a professional R&D team of nearly 60 people and successfully carried out the research and development of more than 30 products. Among them, nearly 10 products have obtained clinical implied licenses, and 12 patents have been independently developed and applied for.

 

Looking ahead to the future, Conlead will rely on its strong research and development capabilities and rich industry experience to strive to develop innovative drugs that can fill market gaps, provide customers with one-stop research and development services, and thus create new productivity. This new type of productivity will not only promote the high-quality development of Conlead itself, but also inject new vitality and momentum into the entire biopharmaceutical industry.
 



-END-
 

轉(zhuǎn)載聲明:未經(jīng)本網(wǎng)或本網(wǎng)權(quán)利人授權(quán),不得轉(zhuǎn)載、摘編或利用其他方式使用上述作品。已經(jīng)本網(wǎng)或本網(wǎng)權(quán)利人授權(quán)使用作品的,應(yīng)在授權(quán)范圍內(nèi)使用,并注明“來源:新領(lǐng)先醫(yī)藥科技”。

Recommend

老熟女重囗味hdxx70星空| 999热线在线观看| 草草久久久亚洲av成人片| 亚洲成av人片天堂网| 男人又粗又大又猛又硬| 国产无遮挡裸体免费视频在线观看| 少妇愉情理伦片高潮日本| 中文区中文字幕免费看 | 亚洲av天堂综合网久久| 久久午夜伦鲁片免费无码| 中文字幕一区二区| 中文字幕AV人妻一区二区| 欧美日韩亚洲精品| 亚洲av片在线观看| 777久久精品一区二区三区无码| av无码免费一区二区三区 | 国产精品嫩草久久久久| 深田咏美av一区二区三区| 亚洲精品日本久久一区二区三区| 色视频www在线播放国产人成 | 亚洲欧美妆和亚洲妆的区别| 大学生久久香蕉国产线看观看| 亚洲av无码一区二区乱子伦| 亚洲色偷偷综合亚洲av伊人| 日韩精品久久无码中文字幕| 丰满少妇大力进入av亚洲| 成人h动漫精品一区二区| 亚洲国产精品久久久久久| 国产女人高潮视频在线观看| CAOPORN国产精品免费视频| 国产精品麻豆成人av电影艾秋| 亚洲综合无码AV一区二区| 成熟交bgmbgmbgm在线| 久久伊人五月丁香狠狠色| 性之剧毒在线观看| 国产suv排行榜前十名| 精品亚洲国产成人蜜臀AV| 在床上拔萝卜又疼又叫什么病| 亚洲av国产精品无码市川京子| 成人毛片一区二区| av精品爆乳纯肉h漫网站|